Protective immunity to genital herpes simpex virus type 2 infection is mediated by T-bet

Journal of Immunology

Volumn 174, Issue 10, 2005, Pages 6266-6273

  Svensson, Alexandra ^a   Nordstrom, Inger ^a   Sun, Jia Bin ^b   Eriksson, Kristina ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DELAYED HYPERSENSITIVITY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; IMMUNITY; INNATE IMMUNITY; INTERFERON PRODUCTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION; VIRUS TITRATION;

EID: 18744373400     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.10.6266     Document Type: Article

References (48)

1. Halioua, B., and J. E. Malkin. 1999. Epidemiology of genital herpes: recent advances. Eur. J. Dermatol. 9: 177-184.
2. Whitley, R. J. 2002. Herpes simplex virus infection. Semin. Pediatr. Infect. Dis. 13: 6-11.
3. Milligan, G. N. 1999. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2. J. Virol. 73: 6380-6386.
4. Zhao, X., E. Deak, K. Soderberg, M. Linehan, D. Spezzano, J. Zhu, D. M. Knipe, and A. Iwasaki. 2003. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197: 153-162.
5. Malmgaard, L., S. R. Paludan, S. C. Mogensen, and S. Ellermann-Eriksen. 2000. Herpes simplex virus type 2 induces secretion of TL-12 by macrophages through a mechanism involving NF-κB. J. Gen. Virol. 81: 3011-3020.
6. + T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J. Gen. Virol. 82(pt. 4): 845-853.
7. Harandi, A. M., B. Svennerholm, J. Holmgren, and K. Eriksson. 2001. Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired γ interferon-mediated protective immunity J. Virol. 75: 6705-6709.
8. Ashkar, A. A., and K. L. Rosenthal. 2003. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77: 10168-10171.
9. Milligan, G. N., and D. I. Bernstein. 1997. Interferon-γ enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 229: 259-268.
10. - cells. J. Immunol. 160: 4738-4746.
11. Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R. M. Hewick, and et al. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146: 3074-3081.
12. + T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type-specific and differ in symptomatic and asymptomatic HSV-2 infected individuals. J. Gen. Virol. 85: 2139-2147.
13. Singh, R., A. Kumar, W. D. Creery, M. Ruben, A. Giulivi, and F. Diaz-Mitoma. 2003. Dysregulated expression of IFN-γ and IL-10 and impaired IFN-γ-mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection. Clin. Exp. Immunol. 133: 97-107.
14. Blaney, J. E., Jr., E. Nobusawa, M. A. Brehm, R. H. Bonneau, L. M. Mylin, T. M. Fu, Y. Kawaoka, and S. S. Tevethia. 1998. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity. J. Virol. 72: 9567-9574.
15. Wonnacott, K. M., and R. H. Bonneau. 2002. The effects of stress on memory cytotoxic T lymphocyte-mediated protection against herpes simplex virus infection at mucosal sites. Brain Behav. Immun. 16: 104-117.
16. + T cell responses and fail to contain virus infection of the central nervous system. J. Immunol. 166: 1066-1074.
17. Koelle, D. M., C. M. Posavad, G. R. Barnum, M. L. Johnson, J. M. Frank, and L. Corey. 1998. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J. Clin. Invest. 101: 1500-1508.
18. Milligan, G. N., N. Bourne, and K. L. Dudley. 2001. Role of polymorphonuclear leukocytes in resolution of HSV-2 infection of the mouse vagina. J. Reprod. Immunol. 49: 49-65.
19. Spruance, S. L., J. C. Overall, Jr., E. R. Kern, G. G. Krueger, V. Pliam, and W. Miller. 1977. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N. Engl. J. Med. 297: 69-75.
20. Cunningham, A. L., R. R. Turner, A. C. Miller, M. F. Para, and T. C. Merigan. 1985. Evolution of recurrent herpes simplex lesions: an immunohistologic study. J. Clin. Invest. 75: 226-233.
21. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8: 275-283.
22. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8: 383-390.
23. Oxenius, A., U. Karrer, R. M. Zinkernagel, and H. Hengartner. 1999. IL-12 is not required for induction of type 1 cytokine responses in viral infections. J. Immunol. 162: 965-973.
24. Sullivan, B. M., A. Juedes, S. J. Szabo, M. von Herrath, and L. H. Glimcher. 2003. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl Acad. Sci. USA 100: 15818-15823.
25. Peng, S. L., S. J. Szabo, and L. H. Glimcher. 2002. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc. Natl. Acad. Sci. USA 99: 5545-5550.
26. + T cell function by the transcription factor Eomesodermin. Science 302: 1041-1043.
27. Mullen, A. C., F. A. High, A. S. Hutchins, H. W. Lee, A. V. Villarino, D. M. Livingston, A. L. Kung, N. Cereb, T. P. Yao, S. Y. Yang, and S. L. Reiner. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292: 1907-1910.
28. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
29. Hatton, R. D., and C. T. Weaver. 2003. Immunology: T-bet or not T-bet. Science 302: 993-994.
30. Hultgren, O. H., M. Verdrengh, and A. Tarkowski. 2004. T-box transcription-factor-deficient mice display increased joint pathology and failure of infection control during staphylococcal arthritis. Microbes Infect. 6: 529-535.
31. Szabo, S. J., B. M. Sullivan, C. Stemmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295: 338-342.
32. McDermott, M. R., J. R. Smiley, P. Leslie, J. Brais, H. E. Rudzroga, and J. Bienenstock. 1984. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J. Virol. 51: 747-753.
33. Parr, M. B., L. Kepple, M. R. McDermott, M. D. Drew, J. J. Bozzola, and E. L. Parr. 1994. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab. Invest. 70: 369-380.
34. Seth, P., W. E. Rawls, R. Duff, F. Rapp, E. Adam, and J. L. Melnick. 1974. Antigenic differences between isolates of herpesvirus type 2. Intervirology 3: 1-14.
35. Andrei, G., R. Snoeck, and E. De Clercq. 1997. Differential susceptibility of several drug-resistant strains of herpes simplex virus type 2 to various antiviral compounds. Antiviral Chem. Chemother. 8: 457-461.
36. Morrison, L. A., X. J. DaCosta, and D. M. Knipe. 1998. Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge. Virology 243: 178-187.
37. Wallace, M. E., R. Keating, W. R. Heath, and F. R. Carbone. 1999. The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J. Virol. 73: 7619-7626.
38. Jeansson, S., M. Forsgren, and B. Svennerholm. 1983. Evaluation of solubilized herpes simplex virus membrane antigen by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 18: 1160-1166.
39. Ohteki, T. 2002. Critical role for IL-15 in innate immunity. Curr. Mol. Med. 2: 371-380.
40. Townsend, M. J., A. S. Weinmann, J. L. Matsuda, R. Salomon, P. J. Farnham, C. A. Biron, L. Gapin, and L. H. Glimcher. 2004. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 20: 477-494.
41. Yokoyama, W. M., and W. E. Seaman. 1993. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu. Rev. Immunol. 11: 613-635.
42. Kaufmann, Y., J. Davidsohn, M. Levanon, I. Icekson, M. Revel, and B. Ramot. 1991. Lymphokine-activated killer (LAK) cells: interferon-γ synergizes with interleukin-2 to induce LAK cytotoxicity in homogeneous leukemic preparations. Clin. Immunol. Immunopathol. 58: 278-288.
43. Parr, M. B., and E. L. Parr. 1999. The role of γ interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice. Virology 258: 282-294.
44. Milligan, G. N., D. I. Bernstein, and N. Bourne. 1998. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J. Immunol. 160: 6093-6100.
45. Milligan, G. N., and D. I. Bernstein. 1995. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology 212: 481.
46. Gierynska, M., U. Kumaraguru, S. K. Eo, S. Lee, A. Krieg, and B. T. Rouse. 2002. Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes. J. Virol. 76: 6568-6576.
47. Dudley, K. L., N. Bourne, and G. N. Milligan. 2000. Immune protection against HSV-2 in B-cell-deficient mice. Virology 270: 454-463.
48. Corey, L., A. G. Langenberg, R. Ashley, R. E. Sekulovich, A. E. Izu, J. M. Douglas, Jr., H. H. Handsfield, T. Warren, L. Marr, S. Tyring, et al. 1999. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. J. Am. Med. Assoc. 282: 331-340.